200230 — Telcon RF Pharmaceutical Income Statement
0.000.00%
Last trade - 00:00- KR₩51bn
- KR₩97bn
- KR₩38bn
Annual income statement for Telcon RF Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 33,141 | 37,841 | 27,830 | 36,307 | 37,865 |
| Cost of Revenue | |||||
| Gross Profit | 7,292 | 9,125 | 5,664 | 9,587 | 10,309 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 77,194 | 43,494 | 49,298 | 36,666 | 41,154 |
| Operating Profit | -44,053 | -5,653 | -21,468 | -359 | -3,288 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -43,813 | -22,875 | -42,117 | 13,949 | -26,500 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -43,832 | -22,875 | -42,117 | 13,949 | -26,500 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -43,054 | -23,098 | -42,084 | 13,906 | -26,320 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -43,054 | -23,098 | -42,084 | 15,330 | -26,320 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,788 | -2,261 | -2,330 | 1,115 | -1,954 |
| Dividends per Share |